Literature DB >> 2479947

Alveolar soft part sarcoma of the uterine cervix.

A A Sahin1, E G Silva, N G Ordonez.   

Abstract

We describe two cases of alveolar soft part sarcoma (ASPS) that occurred as a primary lesion in the uterine cervix. In both cases, the tumor exhibited the typical histologic features of ASPS. In one case, the material for immunohistochemical staining and electron microscopy was available, and the findings of these studies were consistent with the diagnosis of ASPS. A review of the literature disclosed seven previous cases of ASPS occurring in the female genital tract. The tumor was located in the uterine cervix in only three cases. Although ASPS most commonly involves the soft tissues of the extremities and the head and neck region, it can also occur in rather unusual locations such as the female genital tract. Pathologists should be aware of these unexpected occurrences.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479947

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  4 in total

1.  A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature.

Authors:  Kiyoshi Hasegawa; Ryoko Ichikawa; Risa Ishii; Shuko Oe; Rina Kato; Yoichi Kobayashi; Makoto Kuroda; Yasuhiro Udagawa
Journal:  Int J Clin Oncol       Date:  2011-04-26       Impact factor: 3.402

2.  Alveolar soft-part sarcoma of the uterine corpus: histological, immunocytochemical and ultrastructural study of a case.

Authors:  L Guillou; E Lamoureux; S Masse; J Costa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 3.  Alveolar soft part sarcoma of the uterine corpus with pelvic lymph node metastasis: case report and literature review.

Authors:  Lei-lei Zhang; Qian Tang; Zhen Wang; Xiang-sheng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

4.  Uncommon sarcomas of the uterine cervix: a review of selected entities.

Authors:  Oluwole Fadare
Journal:  Diagn Pathol       Date:  2006-09-18       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.